Answer to Question 1
2
Rationale 1:Sotalol (Betapace) is a potassium channel blocker as well as a nonselective beta-adrenergic blocker, and is reserved for serious ventricular dysrhythmias.
Rationale 2:Sotalol (Betapace) is a potassium channel blocker as well as a nonselective beta-adrenergic blocker, and is reserved for serious ventricular dysrhythmias.
Rationale 3:Sotalol (Betapace) is a potassium channel blocker as well as a nonselective beta-adrenergic blocker, and is reserved for serious ventricular dysrhythmias.
Rationale 4:Sotalol (Betapace) is a potassium channel blocker as well as a nonselective beta-adrenergic blocker, and is reserved for serious ventricular dysrhythmias.
Global Rationale: Sotalol (Betapace) is a potassium channel blocker as well as a nonselective beta-adrenergic blocker, and is reserved for serious ventricular dysrhythmias. This medication is not used to treat hypertension, atrial dysrhythmia, or chronic atrial fibrillation.
Answer to Question 2
3
Rationale 1: High dosages of medication will have to be administered because the difference between the optimal therapeutic dose and the toxic dose is very narrow.
Rationale 2:Continual ECG monitoring will be necessary is incorrect because the client might not be on a continuous ECG monitor.
Rationale 3: The difference between the optimal therapeutic dose and the toxic dose is very narrow. As such, antidysrhythmic medications have the potential to correct dysrhythmias, but they also have the ability to worsen or even create new dysrhythmias. Often, the client is hospitalized during the initial stage so that the optimum dose can be accurately determined.
Rationale 4:The client will be able to recover sooner is incorrect because the client is often hospitalized during the initial stage so that the optimum dose can be accurately determined.
Global Rationale: The difference between the optimal therapeutic dose and the toxic dose is very narrow. As such, antidysrhythmic medications have the potential to correct dysrhythmias, but they also have the ability to worsen or even create new dysrhythmias. Often, the client is hospitalized during the initial stage so that the optimum dose can be accurately determined.
Establishing a caring and trusting relationship helps the client come to terms with a terminal illne
The nurse applies a pulse oximeter sensor on the client’s finger.
The nurse uses a noninvasive bladder ultrasound to measure the client’s bladder volume.
A nurse communicates with her non–English-speaking patient through an interpreter
Magnet hospital nurse requirements
Use face cradle covers to prevent the client’s skin from touching the face cradle upholstery.